{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:22:28Z","timestamp":1776702148689,"version":"3.51.2"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.sleep.2023.10.005","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T06:33:29Z","timestamp":1696833209000},"page":"116-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Pitolisant-supported bridging during drug holidays to deal with tolerance to modafinil in patients with narcolepsy"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9854-4038","authenticated-orcid":false,"given":"Yaroslav","family":"Winter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Kallweit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Apel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinzenz","family":"Fleischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Ellwardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergiu","family":"Groppa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2023.10.005_bib1","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1474-4422(14)70218-2","article-title":"Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy","volume":"14","author":"Liblau","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.sleep.2023.10.005_bib2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00281-022-00933-9","article-title":"Narcolepsy: a model interaction between immune system, nervous system, and sleep-wake regulation","volume":"44","author":"Latorre","year":"2022","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.sleep.2023.10.005_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40263-019-00689-1","article-title":"Recently approved and upcoming treatments for narcolepsy","volume":"34","author":"Thorpy","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.sleep.2023.10.005_bib4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.sleep.2023.01.022","article-title":"Solriamfetol real world experience study (SURWEY): initiation, titration, safety, effectiveness, and experience during follow-up for patients with narcolepsy from Germany","volume":"103","author":"Winter","year":"2023","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2023.10.005_bib5","unstructured":"Modafinil - Drug Usage Statistics\". ClinCalc. https:\/\/clincalc.com\/DrugStats\/Drugs\/Modafinil, accessed February 2, 2023."},{"key":"10.1016\/j.sleep.2023.10.005_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.sleep.2018.05.027","article-title":"Modafinil: its discovery, the early European and North American experience in the treatment of narcolepsy and idiopathic hypersomnia, and its subsequent use in other medical conditions","volume":"49","author":"Billiard","year":"2018","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2023.10.005_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13387","article-title":"European guideline and expert statements on the management of narcolepsy in adults and children","volume":"30","author":"Bassetti","year":"2021","journal-title":"J Sleep Res"},{"key":"10.1016\/j.sleep.2023.10.005_bib8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/21556660.2020.1745209","article-title":"A review on modafinil: the characteristics, function, and use in critical care","volume":"9","author":"Hashemian","year":"2020","journal-title":"J Drug Assess"},{"key":"10.1016\/j.sleep.2023.10.005_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neurol.2016.09.016","article-title":"French consensus. Type 1 and type 2 Narcolepsy: investigations and follow-up","volume":"173","author":"Monaca","year":"2017","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.sleep.2023.10.005_bib10","doi-asserted-by":"crossref","DOI":"10.5620\/eht.2012.27.e2012007","article-title":"Practical use and risk of modafinil, a novel waking drug","volume":"27","author":"Kim","year":"2012","journal-title":"Environ Health Toxicol"},{"key":"10.1016\/j.sleep.2023.10.005_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/0976-500X.149149","article-title":"A rare case modafinil dependence","volume":"6","author":"Krishnan","year":"2015","journal-title":"J Pharmacol Pharmacother"},{"key":"10.1016\/j.sleep.2023.10.005_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/10401230490453743","article-title":"Modafinil: preclinical, clinical, and post-marketing surveillance--a review of abuse liability issues","volume":"16","author":"Myrick","year":"2004","journal-title":"Ann Clin Psychiatr"},{"key":"10.1016\/j.sleep.2023.10.005_bib13","series-title":"NICE Evidence Reviews Collection. Withdrawal from pharmacological treatment and drug holidays: attention deficit hyperactivity disorder: diagnosis and management: evidence review I","author":"National Guideline","year":"2018"},{"key":"10.1016\/j.sleep.2023.10.005_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40263-020-00703-x","article-title":"Pitolisant: a review in narcolepsy with or without cataplexy","volume":"34","author":"Lamb","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.sleep.2023.10.005_bib15","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1378\/chest.14-0970","article-title":"International classification of sleep disorders-third edition: highlights and modifications","volume":"146","author":"Sateia","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.sleep.2023.10.005_bib16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1124\/jpet.121.000978","article-title":"Attenuation of response to repeated drug administration: a proposal for differentiating tachyphylaxis and tolerance","volume":"381","author":"Svensson","year":"2022","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.sleep.2023.10.005_bib17","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.10.005_bib18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2869.1994.tb00104.x","article-title":"The Ullanlinna Narcolepsy Scale: validation of a measure of symptoms in the narcoleptic syndrome","volume":"3","author":"Hublin","year":"1994","journal-title":"J Sleep Res"},{"key":"10.1016\/j.sleep.2023.10.005_bib19","first-page":"3","article-title":"Die deutsche Version des EuroQol-Fragebogens","volume":"6","author":"Graf","year":"1998","journal-title":"Zeitschrift f\u00fcr Gesundheitswissenschaften = Journal of public health"},{"key":"10.1016\/j.sleep.2023.10.005_bib20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1389-9457(00)00031-9","article-title":"Long-term efficacy and safety of modafinil (PROVIGIL((R))) for the treatment of excessive daytime sleepiness associated with narcolepsy","volume":"1","author":"Mitler","year":"2000","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2023.10.005_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12080959","article-title":"Tolerance to stimulant medication for attention deficit hyperactivity disorder: literature review and case report","volume":"12","author":"Handelman","year":"2022","journal-title":"Brain Sci"},{"key":"10.1016\/j.sleep.2023.10.005_bib22","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.2147\/DDDT.S101145","article-title":"Profile of pitolisant in the management of narcolepsy: design, development, and place in therapy","volume":"12","author":"Romigi","year":"2018","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.sleep.2023.10.005_bib23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1474-4422(16)30333-7","article-title":"Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial","volume":"16","author":"Szakacs","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.sleep.2023.10.005_bib24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1474-4422(20)30354-9","article-title":"Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial","volume":"20","author":"Nourbakhsh","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.sleep.2023.10.005_bib25","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.npp.1301534","article-title":"Modafinil: a review of neurochemical actions and effects on cognition","volume":"33","author":"Minzenberg","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.sleep.2023.10.005_bib26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bbr.2006.10.016","article-title":"Modafinil enhances extracellular levels of dopamine in the nucleus accumbens and increases wakefulness in rats","volume":"176","author":"Murillo-Rodr\u00edguez","year":"2007","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.sleep.2023.10.005_bib27","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jama.2009.351","article-title":"Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications","volume":"301","author":"Volkow","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.sleep.2023.10.005_bib28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2147\/NSS.S264140","article-title":"Pitolisant to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy: rationale and clinical utility","volume":"12","author":"Guevarra","year":"2020","journal-title":"Nat Sci Sleep"},{"key":"10.1016\/j.sleep.2023.10.005_bib29","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S1474-4422(13)70225-4","article-title":"Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial","volume":"12","author":"Dauvilliers","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.sleep.2023.10.005_bib30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.sleep.2006.10.010","article-title":"Health-related quality of life in patients with narcolepsy","volume":"8","author":"Dodel","year":"2007","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2023.10.005_bib31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.yebeh.2017.12.037","article-title":"Health-related quality of life in patients with poststroke epilepsy","volume":"80","author":"Winter","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.sleep.2023.10.005_bib32","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1159\/000325829","article-title":"Health-related quality of life in multiple system atrophy and progressive supranuclear palsy","volume":"8","author":"Winter","year":"2011","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.sleep.2023.10.005_bib33","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s00415-009-5389-7","article-title":"Social and clinical determinants of quality of life in Parkinson's disease in Austria: a cohort study","volume":"257","author":"Winter","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.sleep.2023.10.005_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107692","article-title":"Screening for health-related quality of life and its determinants in Fabry disease: a cross-sectional multicenter study","volume":"140","author":"Winter","year":"2023","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.sleep.2023.10.005_bib35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40263-021-00886-x","article-title":"Clinical impact of pitolisant on excessive daytime sleepiness and cataplexy in adults with narcolepsy: an analysis of randomized placebo-controlled trials","volume":"36","author":"Meskill","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.sleep.2023.10.005_bib36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.sleep.2022.08.005","article-title":"Effects of solriamfetol treatment on body weight in participants with obstructive sleep apnea or narcolepsy","volume":"100","author":"Malhotra","year":"2022","journal-title":"Sleep Med"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945723003738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945723003738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:46:24Z","timestamp":1761407184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945723003738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":36,"alternative-id":["S1389945723003738"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2023.10.005","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pitolisant-supported bridging during drug holidays to deal with tolerance to modafinil in patients with narcolepsy","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2023.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}